Profile
ACRV NVO VRTX REGN MRNA SGEN
Company Name Acrivon Therapeutics, Inc. Common Stock Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $270.78M $563.06B $109.10B $105.53B $44.96B $43.15B
Employees 0.06K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Dr. Peter Blume-Jensen M.D., Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ACRV NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 5 5 5 2 3
Quant Rating Sell Strong Buy Strong Buy Strong Buy Sell Neutral
Trading
ACRV NVO VRTX REGN MRNA SGEN
Last Close $8.77 $128.42 $422.78 $973.8 $117.31 $228.74
High 52 $14.02 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $3.4 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High -37.45 % -35.64 % -5.22 % -1.97 % -14.84 % -0.07 %
Price vs. 52 Week Low 157.94 % 46.3 % 30.66 % 40.63 % 68.77 % 21.9 %
Total Return
ACRV NVO VRTX REGN MRNA SGEN
1 Month Return -5.6 % 2.41 % 5.63 % 5.81 % 9.63 % 0 %
3 Month Return 141.6 % 5.96 % -0.03 % 2.14 % 34.21 % 0 %
6 Month Return 100.46 % 26.91 % 13.15 % 21.89 % 67.47 % 7.03 %
9 Month Return -29.22 % -29.28 % 20.84 % 20.68 % 15.59 % 17.5 %
YTD Return 78.25 % 24.14 % 3.91 % 10.87 % 17.96 % 0 %
1 Year Return -36.03 % -24.01 % 20.66 % 30.61 % -8.64 % 14.66 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRV NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -33.11 % 1.1 % 13.85 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ACRV NVO VRTX REGN MRNA SGEN
Asset Growth -23.71 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth 51.05 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth - 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -105.89 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -103.48 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -975.3 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share -975.3 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -975.3 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -105.89 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -41.58 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG -1337.31 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG -1337.31 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -1337.31 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -102.96 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -102.96 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -29.41 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 1461.07 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share 1461.07 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 1461.07 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -6.39 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -36.07 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ACRV NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM - 84.65 % 86.91 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -42.49 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -41.3 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -53.7 % 82.5 % 21.07 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 97.29 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 89.99 % 101.7 % 112.45 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM - 45.03 % 41.62 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -918.2 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM - 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.22 2.88 0.42 2.51 22.04 2.52
Inventory Turnover TTM - 1.12 1.64 0.62 13.67 1.07
Fixed Asset Turnover TTM - 248.64 % 685.54 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM - 81.71 % 42.58 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -1.91 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -1.97 11.28 14.17 36.87 -9.61 -3.73
Cash Per Share TTM 570.65 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM - 38.24 % 38.72 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.02 % 53.85 % 92.78 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -918.2 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -6.16 77.52 29.81 26.55 -12.24 -61.54
Price To Operating Cash Flows Ratio TTM -4.59 42.47 27.68 22.15 -15.55 -79.67
Price Cash Flow Ratio TTM -4.59 42.47 27.68 22.15 -15.55 -79.67
Income Statement (TTM)
ACRV NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.07B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.06B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -2.74 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ACRV NVO VRTX REGN MRNA SGEN
Long Term Debt $0B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.02B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.12B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.09B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.14B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ACRV NVO VRTX REGN MRNA SGEN
Net Income $-0.06B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.78
ABCL AbCellera Biologics Inc. 3.83
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 3.47
ABOS Acumen Pharmaceuticals, Inc. 3.36
ABSI Absci Corporation 4.91
ABUS Arbutus Biopharma Corporation 2.88
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 14.09
ACAD ACADIA Pharmaceuticals Inc. 15.25
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.47
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9401
ACHV Achieve Life Sciences, Inc. 4.61
ACIU AC Immune SA 2.31
ACLX Arcellx, Inc. 49.74
ACST Acasti Pharma Inc. 2.76
ACXP Acurx Pharmaceuticals, Inc. 2.03
ETFs With Exposure to ACRV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00366 204.29
VTI Vanguard Total Stock Market Index Fund 0 258.05
SCHB Schwab U.S. Broad Market ETF 0.000207079 60.61
SCHA Schwab U.S. Small-Cap ETF 0.00315366 48.03
IWN iShares Russell 2000 Value ETF 0.00812 156.19
IWO iShares Russell 2000 Growth ETF 0.00305 259.92
VXF Vanguard Extended Market Index Fund 0 170.59
HDG ProShares Hedge Replication ETF 0.000713727 49.2889
UWM ProShares Ultra Russell2000 0.00131668 38.06
VTHR Vanguard Russell 3000 Index Fund 0 231.27
IWC iShares Micro-Cap ETF 0.02427 117.111
URTY ProShares UltraPro Russell2000 0.00066221 45.05
VTWV Vanguard Russell 2000 Value Index Fund 0.01 137.37
VTWO Vanguard Russell 2000 Index Fund 0 82.6
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 89.47
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 89.45
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.27
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.27
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.27
RYLD Global X Russell 2000 Covered Call ETF 0 16.53
VTSAX Vanguard Total Stock Market Index Fund 0 125.62
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 129.48
VITSX Vanguard Total Stock Market Index Fund 0 125.64
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000978454 88.42
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129.49
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00322982 33.19
VEMPX Vanguard Extended Market Index InstlPlus 0 319.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 235.66
Unlock